HF
YTEN

HRT Financial’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

HRT Financial’s Portfolio YTEN Stock Details YTEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-507
Closed -$2K – 3316
2023
Q4 		$2K Buy
507
+70
+16% +$465 ﹤0.01% 2186
2023
Q3 		$3K Buy
+437
New +$11K ﹤0.01% 2228

Other funds holding YTEN

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
CS
Cannell & Spears New York $5.1B AUM 31.77% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
CCB
Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GWM
Grand Wealth Management Grand Rapids, Michigan $212M AUM 18.89% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

HRT Financial's YTEN Position: Q1 2024 in Review

HRT Financial sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q1 2024, closing a stake of 507 shares — an estimated $2K sold.

HRT Financial first reported a position in YTEN in Q3 2023 and held it in 2 quarters. The position peaked at $3K in Q3 2023. 19 funds tracked by Wall St. Rank hold YTEN as of Q1 2024.

  • HRT Financial reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • HRT Financial sold 507 Yield10 Bioscience, Inc. Common Stock shares in Q1 2024, an estimated $2K.
  • HRT Financial first reported a position in Yield10 Bioscience, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
  • HRT Financial's Yield10 Bioscience, Inc. Common Stock position peaked at $3K in Q3 2023.
  • 19 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q1 2024.

Based on HRT Financial's 13F filing for Q1 2024, filed 13 May 2024.